Showing results (2131-2140 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 1, 2000
A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancerG Schwartsmann, H Schunemann, C N Gorini, et al.
Investigational New Drugs|July 30, 1999
Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivoI Pastrone, M Viale, S Cafaggi, et al.
Investigational New Drugs|July 30, 1999
A phase II study of pyrazoloacridine in patients with advanced renal cell carcinomaW J Berg, J McCaffrey, L H Schwartz, et al.
Investigational New Drugs|July 30, 1999
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinomaR Pazdur, D C Medgyesy, R J Winn, et al.
Investigational New Drugs|January 19, 2000
Activity of doxorubicin covalently bound to a novel human serum albumin microcapsuleM Eatock, N Church, R Harris, et al.
Investigational New Drugs|June 9, 1999
Effects of SW 33377, SW 68210 and SW 71425 thioxanthones on in vitro colony formation of freshly explanted human tumor cellsE Izbicka, R Lawrence, K Davidson, et al.
Investigational New Drugs|June 9, 1999
Phase I study of paclitaxel administered by ten-day continuous infusionR J Shade, K M Pisters, M H Huber, et al.
Investigational New Drugs|June 9, 1999
Phase I and pharmacologic study of oral (E)-2'-deoxy-2'-(fluoromethylene) cytidine: on a daily x 5-day scheduleN Masuda, S Negoro, K Takeda, et al.
Investigational New Drugs|June 9, 1999
Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experienceJ Latreille, K A Gelmon, V Hirsh, et al.
Investigational New Drugs|June 9, 1999
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group studyW E Samlowski, D Lew, P J Kuebler, et al.
Pageof 372